Currently Recruiting
Treating Insomnia Related Emotion Brain Dysregulation (TIRED-Brain)
We are looking at how improving sleep improves neuropsychiatric symptoms that are commonly present in individuals between the ages of 25-60 with depression and/or anxiety. This study utilizes high density EEG sleep recordings and neuroimaging.
Looking to Understand Neuropsychiatric Symptoms of Alzheimer's disease (LUNA Study)
We are looking at how improving sleep improves neuropsychiatric symptoms that are commonly present in individuals over the age of 50 with Mild Cognitive Impairment and early Alzheimer's Disease. This study utilizes high-density EEG sleep recordings and neuroimaging.
Investigating Neurocircuit Dysfunction in Cannabis, Alcohol, and Sleep (INDICAS Study)
We are looking at how improving sleep improves withdrawl symptoms that occur in individuals 25-65 who are in withdrawl from co-existing alcohol and cannabis use disorders. This study utilizes high-density EEG sleep recordings and neuroimaging. We are currently recruiting healthy control samples who do not have alcohol and/or cannabis use disorders within the ages of 25-65. Healthy control samples will only undergo high-density EEG sleep recordings and no neuroimaging.
Currently In Analysis
Predictors of Response to Insomnia Treatments for Gulf War Veterans
This study is sponsored by the Department of Veteran Affairs to compare and contrast two non-drug treatments for insomnia in veterans of the Gulf War who are experiencing sleep disturbance.
COVID-19 Pandemic Sleep Study
This research study is examining the impacts of an early sleep intervention on sleep difficulties and neuropsychiatric symptoms that have developed or worsened as a result of the COVID-19 Pandemic and related shelter-in-place restrictions. We hope to learn whether improving sleep early on can prevent more serious, chronic sleep conditions from developing later and improve neuropsychiatric symptoms.
Treatments for Insomnia: Mediators, Moderators, and Quality of Life
This study compares and contrasts non-pharmocological treatments for insomnia in individuals ages 60 and older.